Sporothrix schenckii and general aspects of sporotrichosis

Dimorphic Fungi: Their importance as Models for Differentiation and Fungal Pathogenesis

Volumn , Issue , 2012, Pages 67-86

  Lopes Bezerra, Leila M ^a   Nascimento, Rosana C ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Clinical diagnosis; Epidemiology; Host fungus interplay; Mycosis; Phenotypic analysis; Saprophytic; Sporothrix schenckii; Sporotrichosis; Taxonomy; Thermotolerance; Virulence factors

Indexed keywords

EID: 84882734731     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805364311201010067     Document Type: Chapter

References (155)

1. Lopes-Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc 2006;78: 293-308.
2. Madrid H, Cano J, Gené J, Bonifaz A, Toriello C, Guarro J. Sporothrix globosa, a pathogenic fungus with widespread geographical distribution. Rev Iberoam Micol 2009; 26: 218-222.
3. de Oliveira MM, de Almeida-Paes R, de Medeiros Muniz M, de Lima Barros MB, Galhardo MC, Zancope-Oliveira RM. Sporotrichosis caused by Sporothrix globosa in Rio de Janeiro, Brazil: case report. Mycopathologia 2010; 169: 359-63.
4. Marimon R, Cano J, Gené J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 2007; 45: 3198-3206.
5. Reed KD, Moore FM, Geiger GE, Stemper ME. Zoonotic transmission of sporotrichosis: case report and review. Clin Infect Dis 1993, 16: 384-387.
6. Fleury RN, Taborda PR, Gupta AK, Fujita MS, Rosa PS, Weckwerth AC, et al. Zoonotic sporotrichosis. Transmission to humans by infected domestic cat scratching: report of four cases in São Paulo, Brazil. Int J Dermatol 2001; 40: 318-22.
7. Kovarik CL, Neyra E, Bustamante B. Evaluation of cats as the source of endemic sporotrichosis in Peru. Med Mycol 2008; 46: 53-56.
8. Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis 2008, 21: 129-33.
9. Yegneswaran PP, Sripathi H, Bairy I, Lonikar V, Rao R, Prabhu S. Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Karnataka, India. Int J Dermatol 2009; 48: 1198-2000.
10. de Lima Barros MB, de Oliveira Schubach A, Galhardo MC, Schubach TM, dos Reis RS, Conceição MJ, do Valle AC. Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol 2003; 42: 677-681.
11. Barros MB, Costa DL, Schubach TM, do Valle AC, Lorenzi NP, Teixeira JL, Schubach AO. Endemic of zoonotic sporotrichosis: profile of cases in children. Pediatr Infect Dis J 2008; 27: 246-250.
12. Orofino-Costa R, Bóia MN, Magalhães GA, Damasco PS, Bernardes-Engemann AR, Benvenuto F, et al. Arthritis as a hypersensitivity reaction in a case of sporotrichosis transmitted by a sick cat: clinical and serological follow up of 13 months. Mycoses 2010; 53: 81-83.
13. Freitas DF, do Valle AC, de Almeida Paes R, Bastos FI, Galhardo MC. Zoonotic Sporotrichosis in Rio de Janeiro, Brazil: a protracted epidemic yet to be curbed. Clin Infect Dis 2010; 50: 453.
14. Rippon JW. Sporotrichosis. In: Rippon JW. Medical Mycology: The pathogenic fungi and the pathogenic actinomycetes. Philadelphia, WB Saunders, 1988; pp. 325-352.
15. Hektoen L, Perkins CF. Refractory subcutaneous caused by Sporothrix schenckii. A new pathogenic fungus. J Exp Med 1900; 5: 77-89.
16. Mariat F, de Bievre C. Growth characteristics and development of the content of cellular constituents of yeast and mycelial phases of Sporotrichum schenckii, dimorphic fungus poisonous to man. Ann Inst Pasteur (Paris) 1968; 115: 1082-1098.
17. Lutz A, Splendore A. Sobre uma mycose observada em homens e ratos. Rev Med Sao Paulo 1907; 21: 433-450.
18. Marimon R, Gené J, Cano J, Trilles L, dos Santos Lazéra M, Guarro J. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol 2006; 44: 3251-3256.
19. Arrillaga-Moncrieff I, Capilla J, Mayayo E, Marimon R, Mariné M, Gené J at al. Different virulence levels of the species of Sporothrix in a murine model. Clin Microbiol Infect 2009; 15: 651-655.
20. Mesa-Arango AC, del Rocío Reyes-Montes M, Pérez-Mejía A, Navarro-Barranco H, Souza V, Zúñiga G, Toriello C. Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of sporotrichosis. J Clin Microbiol 2002; 40: 3004-3011.
21. Kong X, Xiao T, Lin J, Wang Y, Chen HD. Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection. Clin Microbiol Infect 2006; 12: 1077-1081.
22. de Meyer EM, de Beer ZW, Summerbell RC, Moharram AM, de Hoog GS, Vismer HF, Wingfield MJ. Taxonomy and phylogeny of new wood-and soil-inhabiting Sporothrix species in the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia 2008; 100: 647-661.
23. Ishizaki H, Kawasaki M, Anzawa K, Mochizuki T, Chakrabarti A, Ungpakorn R, et al. Mitochondrial DNA analysis of Sporothrix schenckii in India, Thailand, Brazil, Colombia, Guatemala and Mexico. Nippon Ishinkin Gakkai Zasshi 2009; 50: 19-26
24. Travassos LR, Lloyd KO. Sporothrix schenckii and related species of Ceratocystis. Microbiol Rev 1980; 44: 683-721.
25. Trent JT, Kirsner RS. Identifying and treating mycotic skin infections. Adv Skin Wound Care 2003; 16: 122-129.
26. Heller HM, Fuhrer J. Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS 1991; 5: 1243-1246.
27. al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis 1998; 26: 1403-1406.
28. Morris-Jones R. Sporotrichosis. Clin Exp Dermatol 2002; 27: 427-431.
29. Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 1255-1265.
30. de Albornoz MB, Mendoza M, de Torres ED. Growth temperatures of isolates of Sporothrix schenckii from disseminated and fixed cutaneous lesions of sporotrichosis. Mycopathologia 1986; 95: 81-83.
31. DiNubile MJ. Nodular lymphangitis: a distinctive clinical entity with finite etiologies. Curr Infect Dis Rep 2008; 10: 404-410.
32. Figueiredo CC, Deccache PM, Lopes-Bezerra LM, Morandi V. TGF-beta1 induces transendothelial migration of the pathogenic fungus Sporothrix schenckii by a paracellular route involving extracellular matrix proteins. Microbiology 2007; 153: 2910-21.
33. Kauffman CA. Sporotrichosis. Clin Infect Dis 1999; 29: 231-236.
34. Kohler LM, Hamdan JS, Ferrari TC. Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing. Diagn Microbiol Infect Dis 2007; 58: 117-120.
35. Howell SJ, Toohey JS. Sporotrichal arthritis in south central Kansas. Clin Orthop Relat Res 1998; 346: 207-214.
36. Orofino-Costa R, de Mesquita KC, Damasco PS, Bernardes-Engemann AR, Dias CM, Silva IC, Lopes-Bezerra LM. Infectious arthritis as the single manifestation of sporotrichosis: serology from serum and synovial fluid samples as an aid to diagnosis. Rev Iberoam Micol 2008; 25: 54-56.
37. Rex JH, Okhuysen PC. Sporotrichosis. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of Infectious Diseases. Local: Churchill Livingstone, 2000.
38. Koëter S, Jackson RW. Successful total knee arthroplasty in the presence of sporotrichal arthritis. Knee 2006; 13: 236-7.
39. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol 2005; 53: 931-51, quiz 952-954.
40. Vieira-Dias D, Sena CM, Oréfice F, Tanure MA, Hamdan JS. Ocular and concomitant cutaneous sporotrichosis. Mycoses 1997; 40: 197-201.
41. Aarestrup FM, Guerra RO, Vieira BJ, Cunha RM. Oral manifestation of sporotrichosis in AIDS patients. Oral Dis 2001; 7: 134-136.
42. Khabie N, Boyce TG, Roberts GD, Thompson DM. Laryngeal sporotrichosis causing stridor in a young child. Int J Pediatr Otorhinolaryngol 2003; 67: 819-823.
43. Fontes PC, Kitakawa D, Carvalho YR, Brandão AA, Cabral LA, Almeida JD. Sporotrichosis in an HIV-positive man with oral lesions: a case report. Acta Cytol 2007; 51: 648-650.
44. Torrealba JR, Carvalho J, Corliss R, England D. Laryngeal granulomatous infection by Sporothrix schenckii. Otolaryngol Head Neck Surg 2005; 132: 339-340.
45. Gutierrez Galhardo MC, de Oliveira Schubach A, de Lima Barros MB, Moita Blanco TC, Cuzzi-Maya T, Pacheco Schubach TM, et al. Erythema nodosum associated with sporotrichosis. Int J Dermatol 2002; 41: 114-116.
46. Gutierrez-Galhardo MC, Barros MB, Schubach AO, Cuzzi T, Schubach TM, Lazéra MS, Valle AC. Erythema multiforme associated with sporotrichosis. J Eur Acad Dermatol Venereol 2005; 19: 507-509.
47. Rodrigues MT, de Resende MA. Epidemiologic skin test survey of sensitivity to paracoccidioidin, histoplasmin and sporotrichin among gold mine workers of Morro Velho Mining, Brazil. Mycopathologia 1996; 135: 89-98.
48. Sanchez-Aleman MA, Araiza J, Bonifaz A. Isolation and characterization of wild Sporothrix schenkii strains and investigation of sporototrichin reactors. Gac Med Mex 2004; 140: 507-512.
49. Mendez-Tovar LJ, Lemini-Lopez A, Hernandez-Hernandez F, Manzano-Gayosso P, Blancas-espinosa R, López-Martínez R. Mycoses frequency in three communities in the North mountain of the State of Puebla. Gac Med Mex 2003; 139: 118-122.
50. Marques ME, Coelho KI, Sotto MN, Bacchi CEJ Comparison between histochemical and immunohistochemical methods for diagnosis of sporotrichosis. Clin Pathol 1992; 45: 1089-1093.
51. Rodríguez G, Sarmiento L. The asteroid bodies of sporotrichosis. Am J Dermatopathol 1998; 20: 246-249.
52. Gezuele E, Da Rosa D. Importance of the sporotrichosis asteroid body for the rapid diagnosis of sporotrichosis. Rev Iberoam Micol 2005; 22: 147-150.
53. Mendez-Tovar LJ, Anides-Fonseca AE, Pena-Gonzales G, Manzano-Gayosso P, López-Martínez R, Hernández-Hernández F, Almeida-Arvizu VM. Unknown fixed cutaneous sporotrichosis. Rev Iberoam Micol 2004; 21: 150-152.
54. Civila ES, Bonasse J, Conti-Diaz IA, Vignale RA. Importance of the direct fresh examination in the diagnosis of cutaneous sporotrichosis. Int J Dermatol 2004; 43: 808-810.
55. Miranda LH, Quintella LP, Menezes RC, Dos Santos IB, Oliveira RV, Figueiredo FB, Lopes-Bezerra LM, Schubach TM. Evaluation of immunohistochemistry for the diagnosis of sporotrichosis in dogs. Vet J 2011 Jan 7. Epub ahead of print]
56. Nascimento RC, Espíndola NM, Castro RA, Teixeira PA, Loureiro y Penha CV, Lopes-Bezerra LM, Almeida SR. Passive immunization with monoclonal antibody against a 70-kDa putative putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol 2008; 38: 3080-3089.
57. Penha CV, Bezerra LM. Concanavalin A-binding cell wall antigens of Sporothrix schenckii: a serological study. Med Mycol 2000; 38: 1-7.
58. Bernardes-Engemann AR, Costa RC, Miguens BR, Penha CV, Neves E, Pereira BA, et al. Development of an enzyme-linked immunosorbent assay for the serodiagnosis of several clinical forms of sporotrichosis. Med Mycol 2005; 43: 487-493.
59. Almeida-Paes R, Pimenta MA, Monteiro PC, Nosanchuk JD, Zancopé-Oliveira RM. Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole. Clin Vaccine Immunol 2007; 14: 1149-1157.
60. Fernandes GF, Lopes-Bezerra LM, Bernardes-Engemann AR, Schubach TM, Dias MA, Pereira SA, de Camargo ZP. Serodiagnosis of sporotrichosis infection in cats by enzyme-linked immunosorbent assay using a specific antigen, SsCBF, and crude exoantigens. Vet Microbiol 2011; 147: 445-449.
61. Bachmeyer C, Buot G, Binet O, Beltzer-Garelly E, Avram A. Fixed cutaneous sporortrichosis: an unusual diagnosis in West Europe. Clin Exp Dermatol 2006; 31: 479-481.
62. Quintal D. Sporotrichosis infection on mines of the Witwatersrand. J Cutan Med Surg 2000; 4: 51-4.
63. Conias S, Wilson P. Epidemic cutaneous sporotrichosis: report of 16 cases in Queensland due to mouldy hay. Australas J Dermatol 1998; 39: 34-37.
64. Dixon DM, Salkin IF, Duncan RA, Hurd NJ, Haines JH, Kemma ME, Coles FB. Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis. J Clin Microbiol 1991; 29: 1106-1113.
65. Kusuhara M, Hachisuka H, Sasai Y. Statistical survey of 150 cases with sporotrichosis. Mycopathologia 1988; 102: 129-133.
66. Haldar N, Sharma MK, Gugnani HC. Sporotrichosis in north-east India. Mycoses 2007; 50: 201-204.
67. Devi KR, Devi MU, Singh TN, Devi KS, Sharma SS, Singh LR, et al. Emergence of sporottrichosis in Manipur. Indian J Med Microbiol 2006; 24: 216-219.
68. Mehta KI, Sharma NL, Kanga AK, Mahajan VK, Ranjan N. Isolation of Sporothrix schenckii from the environmental sources of cutaneous sporotrichosis patients in Himachal Pradesh, India: results of a pilot study. Mycoses 2007; 50: 496-501.
69. Beaman MH. Sporotrichosis in Western Australia. Microbiology Australia 2002; 23:16.
70. Feeney KT, Arthur IH, Whittle AJ, Altman SA, Speers DJ. Outbreak of sporotrichosis, Western Australia. Emerg Infect Dis 2007; 13: 1228-1231.
71. O'Reilly LC, Altman SA. Macrorestrition analysis of clinical and environmental isolates of Sporothrix schenckii. J Clin Microbiol 2006; 44: 2547-2552.
72. Barros MB, de Almeida Paes R, Schubach A. Sporothrix schenckii and sporotrichosis. Clin Microbiol Rev 2011; 24: 633-654.
73. Pappas PG, Tellez I, Deep AE, Nolasco D, Holgado W, Bustamante B. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 2000; 30: 65-70.
74. Macotela-Ruiz E, Nochebuena-Ramos E. Sporotrichosis among rural communities in the Northern Sierra in Puebla. Report of 55 cases September 1995 - December 2005. Gac Med Mex 2006; 142: 377-380.
75. Castro LGM, Salebian A. Variation in frequency of sporotrichosis at the Dermatology Clinic of "Hospital das Clínicas da Faculdade de Medicina da USP" - São Paulo, Brazil. An Bras Dermatol 1989; 64: 15-19.
76. Conti-Díaz IA. Epidemiology of sporotrichosis in Latin America. Mycopathologia 1989; 108: 113-116.
77. González-Ochoa A. Contribuciones recientes al conocimento de la esporotrichosis. Gac Med Mex 1965; 95: 463-474.
78. Findlay GH, Vismer HF, Dreyer L. Studies on sporotrichosis. Pathogenicity and morphogenesis in the Transvaal strains of Sporothrix schenckii. Mycopathologia 1984; 30: 85-93.
79. Vismer HF, Hull PR. Prevalence, epidemiology and geographical distribution of Sporothrix schenckii infections in Gauteng, South Africa. Mycopathologia 1997; 137: 137-143.
80. Mackinnon JE, Conti-Díaz IA, Gezuele E, Civila E, da Luz S. Isolation of Sporothrix schenckii from nature and considerations on its pathogenicity and ecology. Sabouraudia 1969; 7: 38-45.
81. Mayorga R, Cáceres A, Torriello C, Gutiérrez G, Alvarez O, Ramirez ME, Mariat F. An endemic area of sporotrichosis in Guatemala. Sabouraudia 1978; 16: 185-198.
82. Cooper CR, Dixon DM, Salkin IF. Laboratory-acquired sporotrichosis. J Med Vet Mycol 1992; 30: 169-171.
83. Rubio G, Sánchez G, Porras L, Alvarado Z. Sporotrichosis: prevalence, clinical and epidemiological features Iná reference Center in Colombia. Rev Iberoam Micol 2010; 27: 75-79.
84. da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G, Weber A. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol 2005; 52: 451-459.
85. Read SI, Sperling LC. Feline sporotrichosis. Transmission to man. Arch Dermatol 1982; 118: 429-31.
86. Caravalho J Jr, Caldwell JB, Radford BL, Feldman AR. Feline Transmitted sporotrichosis in the southwestern United States. West J Med 1991; 154: 462-465.
87. Barros MB, Schubach A de O, do Valle AC, Gutierrez Galhardo MC, Conceição-Silva F, Schubach TM, et al. Cattransmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infec Dis 2004; 38: 529-535.
88. Kier AB, Mann PC, Wagner JE. Disseminated sporotrichosis in a cat. J Am Vet Med Assoc 1979; 175: 202-204.
89. Dunstan RW, Reimann KA, Langham RF. Feline sporotrichosis J Am Vet Med Assoc 1986; 189: 880-883.
90. Schubach TM, Schubach AO, dos Reis RS, Cuzzi-Maya T, Blanco TCM, Monteiro DF et al. Sporothrix schenckii isolated from domestic cats with and without sporotrichosis in Rio de Janeiro, Brazil. Mycopathologia 2002; 153: 83-86.
91. Larsson CE, Gonçalves MA, Araujo VC, Dagli ML, Correa B, Fava Neto C. Feline sporotrichosis: clinical and zoonotic aspects. Rev Inst Med Trop Sao Paulo 1989; 31: 351-358.
92. Nobre MO, Castro AP, Caetano D, Souza LL, Meireles MCA, Ferreiro L. Recurrence of sporotrichosis in cats wwith zoonotic involvement. Rev Iberoam Micol 2001; 18: 1371-40.
93. Davies C, Troy GC. Deep Mycotic infections in cat. J Am Anim Hosp Assoc 1996; 32: 380-391.
94. Marques SA, Franco SR, de Camargo RM, Dias LD, Haddad V Jr, Fabris VE. Sporotrichosis of the domestic cat (Felis catus): human transmission. Rev Inst Med Trop Sao Paulo 1993; 35: 327-330.
95. Souza LL, Nascente PS, Nobre MO, Meinerz ARM, Meireles MCA. Isolation of Sporothrix schenckii from the nails of healthy cats. Braz J Microbiol 2006; 37: 372-374.
96. Crothers SL, White SD, Ihrke PJ, Affolter VK. Sporotrichosis: a retrospective evaluation of 23 cases seen in northern California (1987-2007). Vet Dermatol 2009; 20: 249-259.
97. Casadevall A, Pirofski LA. Virulence factors and their mechanism of action: the view from a damage-response framework. J Water Health 2009; Suppl 1: S2-S18.
98. Bourgeois C, Majer O, Frohner IE, Tierney L, Kuchler K. Fungal attacks on mammalian hosts: pathogen elimination requires sensing and testing. Curr Opin Microbiol 2010; 13: 401-408.
99. Latgé JP. Tasting the fungal cell wall. Cell Microbiol 2010; 12: 863-872.
100. Tronchin G, Pihet M, Lopes-Bezerra LM, Bouchara JP. Adherence mechanisms in human pathogenic fungi. Med Mycol 2008; 46: 749-772.
101. Klis FM, Brul S, De Groot PW. Covalently linked wall proteins in ascomycetous fungi. Yeast 2010; 27: 489-93.
102. Lane JW, Garrison RG, Field MF. Ultrastrutural studies on the yeast-like and mycelia phases of Sporotrichum schenckii. J Bateriol 1969; 100: 1010-1019.
103. Garrison RG, Boyd KS, Mariat F. Ultrastructural studies of the mycelium-to-yeast transformation of Sporothrix schenckii. J Bacteriol 1975; 124: 9599-68.
104. Teixeira PA, de Castro RA, Ferreira FR, Cunha MM, Torres AP, Penha CV, et al. L-DOPA accessibility in culture medium increases melanin expression and virulence of Sporothrix schenckii yeast cell. Med Mycol 2010; 48: 687-95.
105. Previato JO, Gorin PAJ, Haskins RH, Travassos LR. Soluble and insoluble glucans from different cell types of Sporothrix schenckii. Exp Mycol 1979; 3: 92-105.
106. Lloyd KO, Bitoon MA. Isolation and purification of a peptide-rhamnomannan from the yeast form of Sporothrix schenckii. Structural and immunochemical studies. J Immunol 1971; 107: 663-671.
107. Travassos LR, Souza W, Mendonça-Previato L, Lloyd KO. Location and biochemical nature of surface components reacting with concanavalin A in different cell types of Sporothrix schenckii. Exp Mycol 1977; 293-305.
108. Lopes Alves L, Travassos LR, Previato JO, Mendonça-Previato L. Novel antigenic determinants from peptidorhamnomannans of Sporothrix schenckii. Glycobiology 1994; 4: 281-288.
109. Lima OC, Bezerra LM. Identification of a concanavalin A-binding antigen of the cell surface of Sporothrix schenckii. J Med Vet Mycol 1997; 35: 167-172.
110. Mendonça L, Gorin PAJ, Lloyd KO and Travassos LR. Polymorphism of Sporothrix schenckii surface polysaccharides as a function of morphological differentiation. Biochemistry 1976; 15: 2423-2431.
111. Mendonça-Previato L, Gorin PA, Travassos LR. Galactose-containing polysaccharides from the human pathogens Sporothrix schenckii and Ceratocystis stenoceras. Infect Immun 1980; 29: 934-939.
112. Lopes-Alves LM, Mendonça-Previato L, Fournet B, Degand P, Previato JO. O-glycosidically linked oligosaccharides from peptidorhamnomannans of Sporothrix schenckii. Glycoconj J 1992; 9: 75-81.
113. Lima OC, Figueiredo CC, Previato JO, Mendonça-Previato L, Morandi V, Lopes Bezerra LM. Involvement of fungal cell wall components in adhesion of Sporothrix schenckii to human fibronectin. Infect Immun 2001; 69: 6874-6880.
114. Lima OC, Bouchara JP, Renier G, Marot-Leblond A, Chabasse D, Lopes-Bezerra LM. Immunofluorescence and flow cytometry analysis of fibronectin nad laminin binding to Sporothrix schenckii yeast cells and conidia. Microb Pathog 2004; 37: 131-140.
115. Figueiredo CC, de Lima OC, de Carvalho L, Lopes-Bezerra LM, Morandi V. The in vitro interaction of Sporothrix scenckii with human endothelial cells is modulated by cytokines and involves endothelial surface molecules. Microb Pathog 2004; 36: 177-188.
116. Lima OC, Figueiredo CC, Pereira BA, Coelho MG, Morandi V, Lopes-Bezerra LM. Adhesion of human pathogen Sporothrix schenckii to several extracellular matrix proteins. Braz J Med Biol Res 1999; 32: 651-657.
117. Teixeira PA, de Castro RA, Nascimento RC, Tronchin G, Torres AP, Lazéra M, et al. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporotrhix schenckii. Microbiology 2009; 155: 3730-3738.
118. Ruiz-Baca E, Toriello C, Perez-Torres A, Sabanero-Lopez M, Villagomez-Castro JC, Lopez-Romero E. Isolation and some properties of a glycoprotein of 70 kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix. Med Mycol 2009; 47: 185-196.
119. Tsuboi R, Sanada T, Takamori K, Ogawa H. Isolation and properties of extracellular proteinases from Sporothrix schenckii. J Bacteriol 1987; 169: 4104-4109.
120. Tsuboi R, Sanada T, Ogawa H. Influence of culture medium pH and proteinase inhibitors on extracellular proteinase activity and cell growth of Sporothrix schenckii. J Clin Microbiol 1988; 26: 1431-1433.
121. Yoshiike T, Lei PC, Komatsuzaki H, Ogawa H. Antibody raised against extracellular proteinases of Sporothrix schenckii in S. schenkii inoculated hairless mice. Mycopathologia 1993; 123: 69-73.
122. Da Rosa D, Gezuele E, Calegari L, Goñi F. Excretion-secretion products and proteases from live Sporothrix schenckii yeast phase: immunological detection and cleavage of human IgG. Rev Inst Med Trop São Paulo 2009; 51: 1-7.
123. Langfelder K, Streibel M, Jahn B, Haase G, Brakhage AA. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet Biol 2003; 38: 143-158
124. Almeida-Paes R, Frases S, Fialho Monteiro PC, Gutierrez-Galhardo MC, Zancopé-Oliveira RM, Nosanchuck JD. Growth conditions influence melanization of Brazilian clinical Sporothrix schenckii isolates. Microbes Infect 2009; 11: 554-562.
125. Taborda CP, da Silva MB, Nosanchuck JD, Travassos LR. Melanin as a virulence factor of Paracoccidioides brasiliensis and other dimorphic pathogenic fungi: a minireview. Mycopathologia 2008; 165: 331-339.
126. Morris-Jones R, Younchim S, Gomez BL, Aisen P, Hay RJ, Nosanchuck JD, et al. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro nad during mammalian infection. Infect Immun 2003; 71: 402640-33.
127. Romero-Martinez R, Wheeler M, Guerrero-Plata A, Rico G, Torres-Guerrero H. Biosynthesis and functions of melanin in Sporothrix schenckii. Infect Immun 2000; 68: 3696-3703.
128. Hogan LH, Klein BS, Levitz SM. Virulence factors of medically fungi. Clin Microbiol Rev 1996; 9: 469-488.
129. Clemons KV, Darbonne WC, Curnutte JT, Sobel RA, Stevens DA. Experimental histoplasmosis in mice treated with anti-murine interferon-gamma antibody and in interferon-gamma gene knockout mice. Microbes Infect 2000; 9: 997-1001.
130. Stevens DA, Domer JE, Ashman RB, Blackstock R, Brummer E. Immunomodulation in mycoses. J Med Vet Mycol 1994; 32 Suppl 1: 253265.
131. Casadevall A, Cassone A, Bistoni F, Cutler JE, Magliani W, Murphy JW, et al. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med Mycol 1998; 36 Suppl 1: 95-105.
132. Calich VL, da Costa TA, Felonato M, Arruda C, Bernardino S, Loures FV, et al. Innate immunity to Paracoccidioides brasiliensis infection. Mycopathologia 2008, 165: 223-236.
133. Plouffe JF Jr, Silva J Jr, Fekety R, Reinhalter E, Brownw R. Cell mediated immune responses in sporotrichosis. J Infect Dis 1979; 139: 152-157.
134. Gori S, Lupetti A, Moscato G, Parenti M, Lofaro A. Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient. A case report. Acta Cytol 1997; 41: 519-521.
135. de Araujo T, Marques AC, Kerdel F. Sporotrichosis. Int J Dermatol 2001; 40: 737-742.
136. Carlos IZ, Zini MM, Sgarbi DB, Angluster J, Alviano CS, Silva CL. Disturbances in the production of interleukin-1 nad tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia 1994; 127: 189-194.
137. Shiraishi A, Nakagaki K, Arai T. Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 1992; 120: 15-21.
138. Dickerson CL, Taylor RL, Drutz DJ. Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Infect Immun 1983; 40: 417-420.
139. Tanuma H, Asai T, Abe M, Nishiyama S, Katsuoka K. Case report. Lymphatic vessel-type sporotrichosis: immunohistochemical evaluation and cytokine expression pattern. Mycoses 2001; 44: 316-320.
140. Koga T, Duan H, Urabe K, Furue M. Immunohistochemical localization of activated and mature CD83+ dendritic cells in granulomas of sporotrichosis. Eur J Dermatol 2001; 11: 527-529.
141. Koga T, Duan H, Furue M. Immunohistochemical detection of interferon-gamma producing cells in granuloma formation of sporotrichosis. Med Mycol 2002; 40: 111-114.
142. Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999; 37: 397-404.
143. Cunningham KM, Bulmer GS, Rhoades ER. Phagocytosis and intracellular fate of Sporothrix schenckii. J Infect Dis 1979; 140: 815-817.
144. Rex JH, Bennet JE. Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. J Med Vet Mycol 1990; 28: 185-189.
145. Miyaji M, Nishimura K. Defensive role of granuloma against Sporothrix schenckii infection. Mycopathologia 1982; 80: 117-124.
146. Sorimachi K, Akimoto K, Hattori Y, Ieiri T, Niwa A. Secretion of TNF-alpha, IL-8 and nitric oxide by macrophages activated with polyanions, and involvement of interferon-gamma in the regulation of cytokine secretion. Cytokine 1999; 11: 571-578.
147. Silva AC, Bezerra LM, Aguiar TS, Tavares D, Araujo LM, Pinto CE, Ribeiro OG. Effect of genetic modifications by selection for immunological tolerance on fungus infection in mice. Microbes Infect 2001; 3: 215-222.
148. Hiruma N, Yamaji K, Shimizu T, Ohata H, Kukita A. Ultrastructural stdy of tissue reaction of mice against Sporothrix schenckii infection. Arch Dermatol Res 1988; 280: S94-S100.
149. Maia DC, Sassá MF, Placeres MC, Carlos IZ. Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii. Mycopathologia 2006; 161: 11-19.
150. Fernandes KS, Coelho AL, Lopes-Bezera LM, Barja-Fidalgo C. Virulence of Sporothrix schenckii conidia and yeast cells, and their susceptibility to nitric oxide. Immunology 2000; 101: 563-9.
151. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell response: the alternative approache. Annu Rev Immunol 1997; 15: 297-322.
152. Mosmann TR, Coffman RL. TH1 and TH2 cells: different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
153. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 36: 2348-2357.
154. Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000; 21: 479-483.
155. Nascimento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol Med Microbiol 2005; 43: 241-247.